Two vaccines to protect against respiratory syncytial virus (RSV) are now available for those over age 60, but a vaccine to protect young children is still in development. "The Long-Awaited RSV Vaccine" provides an update ...
Jul 21, 2023
0
1
Even low levels of alcohol use can increase the likelihood of developing diseases like cancer and heart disease. A systematic review of studies of the relationship between alcohol use and risk of disease published in Alcohol: ...
Jul 10, 2023
0
21
Half as many children in the United States were diagnosed with asthma in the first year of the COVID-19 pandemic compared to previous years, and Rutgers researchers think fewer colds may be part of the reason.
Apr 1, 2023
0
13
The post-COVID syndrome known as long COVID has four major subtypes defined by different clusters of symptoms, according to a study led by researchers at Weill Cornell Medicine.
Jan 4, 2023
0
107
Researchers have developed a novel device that detects abnormal breathing sounds to predict whether an ICU patient is likely to suffer from respiratory complications after removal from a mechanical ventilator, alerting intensive ...
Dec 16, 2022
0
22
Like Canadian Prime Minister Justin Trudeau and Mexican President Andrés Obrador before him, Prime Minister Anthony Albanese has been infected with COVID for a second time.
Dec 9, 2022
0
24
A new invited perspective from a paper from Columbia University Mailman School of Public Health illustrates the increases in adverse public health outcomes following tropical cyclones, especially in communities with existing ...
Nov 30, 2022
0
0
The World Health Organization said on Monday it was thrashing out a new list of priority pathogens that risk sparking pandemics or outbreaks and should be kept under close observation.
Nov 21, 2022
0
5
Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory disease worldwide and the third leading cause of death. In Germany, about 10% of the population is affected. Fatigue, coughing and persistent ...
Sep 27, 2022
0
126
Pharmaceutical giant Pfizer on Thursday announced positive results in the elderly for a vaccine against respiratory syncytial virus (RSV), for which there are currently no authorized shots.
Aug 25, 2022
0
21
